Arresting Vertical Transmission of Hepatitis B Virus

PHASE4CompletedINTERVENTIONAL
Enrollment

179

Participants

Timeline

Start Date

September 24, 2018

Primary Completion Date

March 6, 2020

Study Completion Date

August 15, 2020

Conditions
Hepatitis BVertical Transmission of Infectious Disease
Interventions
DRUG

Tenofovir Disoproxil Fumarate

300 mg tablet of TDF once daily from 28-32 weeks gestation through 12 weeks postpartum.

BIOLOGICAL

Monovalent HBV vaccine

Infants born to HBsAg-positive women will be given a single dose of monovalent HBV vaccine within 24 hours of life.

Trial Locations (1)

Unknown

Kinshasa School of Public Health, Kinshasa

All Listed Sponsors
collaborator

Kinshasa School of Public Health

OTHER

collaborator

Ohio State University

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT03567382 - Arresting Vertical Transmission of Hepatitis B Virus | Biotech Hunter | Biotech Hunter